Amazon GLP-1 Program Pressures Hims & Hers Stock

Hims & Hers Health Inc. (NYSE:HIMS) stock is trading lower on Tuesday in reaction to Amazon.com Inc. (NASDAQ:AMZN) introducing a comprehensive GLP-1 Management Program through Amazon One Medical.

The program aims to simplify obesity treatment by combining primary care, pharmacy services, and virtual care into a unified platform.

Hims & Hers operates a health and wellness platform and offers GLP-1 drugs and care for weight loss, among other services.

In March, Hims & Hers Health announced that a broad assortment of Novo Nordisk A/S’ (NYSE:NVO) FDA-approved GLP-1 medications are available to eligible customers, including the Wegovy pill.

Expanded Access To GLP-1 Medications

Amazon Pharmacy is central to the initiative, offering transparent pricing and delivery options for GLP-1 medications.

The platform includes newly FDA-approved oral treatments such as Wegovy and Eli Lilly and Co.’s (NYSE:LLY) Foundayo, with insurance-backed pricing starting at $25 per month and cash-pay options from $149.

Injectable options—including Wegovy, Zepbound auto-injector, and KwikPen—are available starting at $299 per month. Medications can be delivered nationwide, with same-day delivery currently available in nearly 3,000 locations and expected to expand to 4,500 by 2026.

Customers can compare insurance and cash prices at checkout, with eligible discounts automatically applied.

Amazon said its pharmacy customers have saved more than $200 million through its coupon program.

In March, Novo Nordisk introduced a multi-month subscription program for its obesity treatment Wegovy (semaglutide).

The subscription program will initially be offered through telehealth providers, including Ro, WeightWatchers, and LifeMD Inc (NASDAQ:LFMD), with platforms such as Hims & Hers Health and Sesame expected to join later.

Flexible Access And Telehealth Support

The program is now available at Amazon One Medical locations across the U.S. Enrolled patients receive prescription renewals through their primary care providers.

For existing GLP-1 users outside the One Medical network, Amazon offers 24/7 telehealth renewal services priced at $29 for messaging consultations and $49 for video visits. The company noted this option is limited to prescription renewals and does not support new prescriptions.

HIMS Stock Price Activity: Hims & Hers shares were down 5.42% at $29.34 at the time of publication on Tuesday, according to Benzinga Pro data.

Image via Shutterstock